Read Dr. Meghan Azad’s informal report on her participation in the 64th Lindau Nobel Laureate Meeting in Lindau, Germany, available here. Dr. Azad thanks the Canadian Institutes of Health Research (CIHR) for nominating her for inclusion in the event and …
AllerGen trainee reports back from meeting with Nobel Laureates Read more »
Dr. Michael Brauer, an AllerGen investigator and a professor in the School of Population and Public Health at The University of British Columbia (UBC), is leading a new study that will provide an unparalleled worldwide analysis of the relationship between …
AllerGen researcher funded to lead worldwide study of air pollution and disease Read more »
Dr. Malcolm Sears, an AllerGen research leader and a professor of medicine at McMaster University, together with a team of CHILD researchers from across Canada, has received a five-year operating grant, valued at over $1 million, from the Canadian Institutes …
CHILD research team awarded five-year CIHR grant Read more »
AllerGen will partner in the Emerging Research Leaders Initiative (ERLI)—an establishment grant program for researchers at the transition stage from post-doctoral fellow to early career professional in the areas of cardiovascular, cerebrovascular, and/or respiratory health research. This multi-partnered initiative is …
An AllerGen investigator is among 90 Canadians named in Thomson Reuters’ new compilation of “The World’s Most Influential Scientific Minds: 2014.” Dr. Fiona Brinkman, a professor in the Department of Molecular Biology and Biochemistry at Simon Fraser University, was ranked …
AllerGen investigator chosen for 2014 “World’s Most Influential Scientific Minds” Read more »
AllerGen investigator Dr. Kelly McNagny (The University of British Columbia) is co-editor of a new edition of Mast Cells: Methods and Protocols, a volume in the Methods in Molecular Biology series published by Humana Press. The text is intended for …
Network members contribute to new volume on the study of mast cells Read more »
Researchers in AllerGen’s Clinical Investigator Collaborative (CIC) have shown that a new drug (quilizumab) successfully blocks the production of an immune system protein, reducing symptoms of allergic asthma. The study, led by Dr. Gail Gauvreau (McMaster University), was conducted by …
CIC investigators test new drug for allergic asthma Read more »
AllerGen trainee and gut microbiome researcher Dr. Meghan Azad has been featured in the “Faces” series leading up to The 64th Lindau Nobel Laureate Meeting (Physiology or Medicine), be held June 29-July 4, 2014, in Lindau, Germany. The “Faces” blog series profiles just a few …
A new study by AllerGen researchers reveals that low-income families affected by food allergies felt “unsafe” procuring allergen-free foods at food banks and discount supermarkets, may be misinformed the social assistance health insurance plan, and distanced themselves from other low-income …
Low income, high risk: the overlapping stigmas of food allergy and poverty Read more »
A new digital media campaign on asthma and allergies featuring an online article about AllerGen’s CHILD Study was released on June 12, 2014. The CHILD Study article provides an introduction to the study, its preliminary findings, and the promise the study holds for …
CHILD Study news to reach 700,000 through Toronto Star Read more »
Anaphylaxis Canada’s “Allergy Pals,” an online peer support and mentorship program for children with severe food allergies, was recently profiled by Global TV News (Edmonton). Dr. Miriam Stewart and a team from the University of Alberta developed the mentoring program …
Researchers at AllerGen’s Clinical Investigator Collaborative (CIC) have discovered that an antibody can block a specific protein in the lungs and reduce the symptoms of inflammation and bronchoconstriction experienced by people with mild allergic asthma. The study, published in the …
CIC investigators publish new findings for allergic asthma Read more »